MedPath

Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia

Not Applicable
Completed
Conditions
Eclampsia
Pre-Eclampsia
Registration Number
NCT03028194
Lead Sponsor
Saint Thomas Hospital, Panama
Brief Summary

Use of Postpartum uterine curettage in reducing hospitalization time or in improving the clinical evolution of the patient with preeclampsia/eclampsia.

Detailed Description

To evaluate if postpartum uterine curettage improved the clinical and laboratory parameters in patients with preeclampsia or eclampsia.

A total of 442 patients with preeclampsia/eclampsia were randomized to postpartum curettage (223) or no procedure (219). Systolic and diastolic blood pressure were recorded and analyzed at hours 6, 12, 24 and 48. Also, several laboratory values and diuresis were evaluated.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
442
Inclusion Criteria
  • Gestational age 24 weeks or more.
  • Preeclampsia/eclampsia
Exclusion Criteria
  • Epilepsy or seizures previous to pregnancy.
  • Renal disease
  • Heart disease
  • Liver disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Systolic and diastolic blood pressure48 hours

Arterial Blood pressure

Secondary Outcome Measures
NameTimeMethod
Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests).48 hours

Number of patients with an abnormal laboratory value

Seizures48 hours

Number of participants with the development of seizures after birth.

Trial Locations

Locations (2)

Saint Thomas H

🇵🇦

Panama, Panama

Saint Thomas Maternity Hospital

🇵🇦

Panama, Panama

Saint Thomas H
🇵🇦Panama, Panama

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.